LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
34.36
+0.45 (1.32%)
Nov 21, 2024, 12:11 PM EST - Market open

LENZ Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.010.01-
Asset Turnover
--0.46-
Quick Ratio
28.163.554.6814.61
Current Ratio
28.633.634.9114.62
Return on Equity (ROE)
-41.90%-157.61%-39.80%-
Return on Assets (ROA)
-27.03%-77.17%-20.07%-
Return on Capital (ROIC)
-29.25%-101.31%-24.01%-
Buyback Yield / Dilution
-486.94%-2.47%-1.05%-
Total Shareholder Return
-486.94%-2.47%-1.05%-
Source: S&P Capital IQ. Standard template. Financial Sources.